Pulmonary embolism and infarction happens when a blood clot blocks blood flow in the lungs and part of the lung tissue is damaged. Early symptoms of pulmonary embolism and infarction can include sudden shortness of breath, sharp chest pain, coughing, or feeling lightheaded. It most often affects adults, especially people with recent surgery, long periods of immobility, cancer, pregnancy, or a past blood clot. Pulmonary embolism and infarction can be life-threatening, but not everyone will have the same experience, and quick treatment often improves the outlook. Treatment usually includes blood-thinning medicine, oxygen and pain relief when needed, and in severe cases clot-busting treatment or a procedure to remove the clot.
How many people live with Pulmonary embolism and infarction?
Because pulmonary embolism is usually counted by how many people are affected each year rather than how many are living with it at one moment, worldwide figures for pulmonary embolism with lung tissue damage are usually estimated from the broader group of venous blood clots: about 10 million cases occur globally each year, which suggests roughly 3 million to 5 million pulmonary embolism cases worldwide, not a direct count (World Thrombosis Day, 2023). In the United States, about 900,000 people each year are affected by a venous blood clot, suggesting roughly 300,000 to 450,000 pulmonary embolism cases annually, again an estimate rather than a direct count (CDC, 2024).
Overview
Pulmonary embolism and infarctionSymptoms
Pulmonary embolism and infarction often cause sudden shortness of breath, sharp chest pain that gets worse with breathing, and a fast heartbeat. Early symptoms of pulmonary embolism can also include coughing, sometimes with blood, feeling lightheaded, or fainting.
Outlook and prognosis
With prompt treatment, many people with pulmonary embolism and infarction recover well, though chest pain, breathlessness, and tiredness can take weeks to ease. Outlook depends on clot size, how quickly treatment starts, and whether heart or lung strain develops.
Causes and risk factors
Pulmonary embolism and infarction usually happens when a blood clot, often from a leg vein, travels to the lungs. Risk rises with surgery, long periods of sitting, cancer, pregnancy, smoking, estrogen medicines, older age, obesity, and inherited clotting disorders.
Genetic influences
Genetics can matter in pulmonary embolism and infarction, but they are usually only part of the risk. Some inherited clotting tendencies can raise the chance of blood clots, while surgery, cancer, pregnancy, hormones, or long periods of immobility often play a bigger role.
Diagnosis
Pulmonary embolism and infarction is usually diagnosed using symptoms, a physical exam, blood tests, and imaging. Doctors often use a CT lung scan or a lung blood-flow scan. Ultrasound of the legs may help find the clot source.
Treatment and drugs
Pulmonary embolism and infarction is usually treated urgently with blood thinners to stop the clot from growing and lower the chance of new clots. Some people also need clot-busting medicine, a catheter procedure, oxygen, and pain relief.
Symptoms
Breathing can suddenly feel harder, even during simple things like walking across a room or climbing a few stairs. Some of the early symptoms of pulmonary embolism and infarction can be easy to mistake for a chest infection, a pulled muscle, or even anxiety. Symptoms vary from person to person and can change over time. Because pulmonary embolism and infarction can become dangerous quickly, sudden chest pain, major shortness of breath, or fainting needs urgent medical care.
Breathlessness often starts suddenly and can happen at rest or with light activity. Many people feel they cannot get a full breath, and some notice rapid breathing or a sense of air hunger. In more severe cases, lips or fingertips may look bluish because oxygen levels are low.
Chest pain is often sharp and tends to get worse with a deep breath, cough, or movement. With pulmonary infarction, the pain may stay in one spot and feel similar to pleurisy, the pain caused by an irritated lung lining.
A cough may be dry at first or bring up a small amount of mucus. If lung tissue has been damaged, the cough can produce blood-streaked sputum and sometimes comes with a mild fever.
The heart may race or pound as the body tries to cope with lower oxygen and reduced blood flow. Some people also feel sweaty, shaky, or suddenly very uneasy at the same time.
How people usually first notice Pulmonary embolism and infarction?
Pulmonary embolism and infarction often announces itself suddenly: you may be going about a normal day when shortness of breath, sharp chest pain that gets worse with a deep breath, or an unexplained racing heartbeat appears out of nowhere. Many people first notice pulmonary embolism after feeling unusually breathless with mild activity or at rest, and some also cough, feel lightheaded, or cough up a small amount of blood, especially if part of the lung has been damaged by infarction, which means loss of blood flow to lung tissue. Because these first signs of pulmonary embolism can be mistaken for anxiety, a pulled muscle, or a chest infection, sudden breathing trouble or chest pain needs urgent medical attention.
Types of Pulmonary embolism and infarction
Pulmonary embolism and infarction can show up in a few different patterns, and the day-to-day experience often depends on how large the clot is, where it lodges, and whether part of the lung loses blood flow. Symptoms don’t always look the same for everyone. When doctors talk about the types of pulmonary embolism, they usually mean acute versus chronic forms, or they describe how severe the blockage is and whether lung infarction is present.
Acute PE
This is the most common form and starts suddenly, often with shortness of breath, chest pain, a fast heartbeat, or coughing. Some people feel winded walking across a room, while others notice sharp pain when taking a deep breath. Symptoms can range from mild to severe depending on how much of the lung circulation is blocked.
High-risk PE
This is a severe acute pulmonary embolism that causes major strain on the heart and can lead to very low blood pressure, fainting, or collapse. People with this type often look and feel suddenly very unwell rather than just short of breath. It needs emergency treatment right away.
Intermediate-risk PE
In this type, blood pressure stays normal, but the clot is still stressing the heart. Many living with pulmonary embolism in this group have chest pain, breathlessness, or low oxygen levels, and tests may show heart strain even if they are not in shock. Symptoms can worsen over hours, so close medical monitoring is important.
Low-risk PE
This type causes symptoms but does not appear to be putting major strain on the heart. Some may find the main problem is breathlessness with activity, mild chest discomfort, or unexplained fatigue rather than dramatic collapse. Many people are stable enough for less intensive treatment once doctors confirm it is safe.
Saddle PE
This clot sits where the main lung artery splits into right and left branches. It may cause severe shortness of breath, chest pressure, dizziness, or fainting, but some people have fewer symptoms than the clot size suggests. The main concern is the potential for sudden heart strain.
Pulmonary infarction
This happens when a clot blocks blood flow enough to damage a small area of lung tissue, usually near the outer edge of the lung. It often causes sharp pain that gets worse with breathing, and coughing up blood can occur. Fever and a small fluid buildup around the lung may also be seen.
Chronic thromboembolic disease
This develops when clots do not fully clear and symptoms continue or return over time. Instead of sudden chest pain, people often notice ongoing shortness of breath, reduced exercise tolerance, and fatigue that slowly interfere with daily life. In some cases, this progresses to chronic thromboembolic pulmonary hypertension, which means high pressure in the lung blood vessels.
Can I slow down the onset of symptoms?
Usually no: a pulmonary embolism, meaning a blood clot in the lung, often causes symptoms suddenly, so there is no proven way to make symptoms start more slowly once a clot has formed. What can help is lowering the chance of the clot happening in the first place by keeping moving, especially during long travel or after surgery or illness, not smoking, and managing weight and other health problems that raise clot risk; for people at higher risk, doctors may also recommend preventive blood thinners and sometimes compression stockings during hospital stays or after certain surgeries. These steps may reduce risk, but they cannot guarantee prevention, so quick medical care for sudden shortness of breath, chest pain, or coughing up blood is still very important.
What genetics can tell you about symptoms
Genetics can sometimes show whether someone has an inherited tendency to form blood clots, which can raise the risk of a pulmonary embolism, but it usually cannot predict the exact symptoms they will have. In most people, symptoms such as sudden shortness of breath, chest pain, coughing, or coughing up blood depend more on the size and location of the clot, whether part of the lung has been damaged, and a person’s overall heart and lung health than on a specific gene change. Some inherited clotting conditions may make events happen at a younger age or increase the chance of repeat clots, but they are not a reliable guide to how severe symptoms will feel in any one episode.
Causes and risk factors
A blood clot often starts in a deep vein in the leg or pelvis and then travels to the lungs. This is the main cause of pulmonary embolism and infarction. Risk goes up after surgery, during a long hospital stay, on long trips, in pregnancy, and with estrogen-based birth control or hormone therapy. Having risk factors doesn’t mean you’ll definitely develop the condition. Older age, cancer, smoking, obesity, a past clot, heart or lung disease, and inherited gene changes that make blood clot too easily can all raise the risk.
What are the most common causes or risk factors?
Pulmonary embolism usually happens when a blood clot, most often from a deep vein in the leg or pelvis, travels to the lungs and blocks blood flow; if the blockage is severe, part of the lung can be damaged, which is called an infarction. The biggest risk factors are long periods of not moving, major surgery or injury, cancer, pregnancy and the weeks after birth, birth control pills or hormone treatment that contain estrogen, smoking, obesity, older age, and having had a blood clot before. Some people also inherit a higher tendency for their blood to clot, which can raise the risk even more, especially when one of these other factors is also present.
Environmental and biological risk factors
Pulmonary embolism happens when a blood clot, usually from a deep vein in the leg or pelvis, travels to the lungs; pulmonary infarction means part of the lung is injured because blood flow is blocked. Most risk factors for pulmonary embolism and infarction either make clots form more easily or make blood move more slowly. Doctors often group risks into internal (biological) and external (environmental).
Sitting or lying still for long periods slows blood flow in the deep veins, especially in the legs. This can happen during bed rest, a hospital stay, paralysis, or long-distance travel.
Major surgery, especially involving the hip, knee, abdomen, or pelvis, can raise clot risk for days to weeks afterward. Serious injury and broken bones can do the same because the body is in a high-clotting state and movement is often reduced.
Cancer can make blood more likely to clot, and the risk may be higher with chemotherapy, some newer cancer drugs, or a central venous catheter. Pulmonary embolism is more likely during active cancer treatment and in the months after diagnosis.
Pregnancy and the first 6 weeks after birth raise clot risk because blood clots more easily and pelvic veins are under more pressure. A cesarean birth, heavy bleeding, or prolonged bed rest can increase the risk further.
Genetic risk factors
A pulmonary embolism can feel like sudden chest pain or shortness of breath, and in some families the risk partly starts with inherited changes that make blood clot more easily. In pulmonary embolism and infarction, the main genetic risks are usually genes that raise the chance of a clot forming in a vein and then traveling to the lungs, where it can sometimes damage lung tissue. Some of the main genetic risk factors for pulmonary embolism are family history, Factor V Leiden, and a few rarer inherited clotting disorders. Carrying a genetic change doesn’t guarantee the condition will appear.
Family history: Having close relatives with deep vein thrombosis or pulmonary embolism can point to an inherited tendency to clot. This can matter even when no specific gene change has been identified.
Factor V Leiden: This inherited change makes one clotting protein harder for the body to switch off. It is the most common inherited clotting risk in people of European ancestry and can raise the chance of pulmonary embolism.
Prothrombin change: A change in the prothrombin gene can lead to higher levels of a protein that helps blood clot. That can increase the risk of deep vein clots and, in turn, clots reaching the lungs.
Antithrombin deficiency: Antithrombin acts like a natural brake on clotting, and some families inherit too little of it or a version that works poorly. Although uncommon, it can strongly raise the risk of serious venous clots.
Protein C deficiency: Protein C helps keep clots from growing too much. When it is inherited at low levels or does not work well, the risk of abnormal vein clots increases.
Protein S deficiency: Protein S works alongside protein C to control clotting. An inherited shortage or reduced function can increase the risk of pulmonary embolism and related clotting problems.
Non-O blood type: People with blood types A, B, or AB have a slightly higher inherited tendency toward venous clots than those with type O. The effect is modest, but it can add to other genetic risks.
Multiple gene changes: Some people inherit more than one clot-related gene change. When these risks occur together, the chance of pulmonary embolism can be higher than with a single inherited risk alone.
Lifestyle risk factors
Several everyday habits can raise the chance of developing blood clots in the legs that can travel to the lungs and cause pulmonary embolism with lung infarction. The most important lifestyle risk factors for pulmonary embolism and infarction are those that promote venous stasis, dehydration, smoking-related vessel injury, and excess body weight. Understanding how lifestyle affects pulmonary embolism and infarction can help lower clot risk, especially in people who already have other medical risk factors.
Long periods of sitting, such as during desk work, gaming, or travel, slow blood flow in the leg veins. This makes clot formation more likely, and a clot can break loose and lodge in the lungs.
A generally inactive lifestyle reduces the muscle pumping action that helps move blood back toward the heart. Regular movement and exercise can improve circulation and lower venous clot risk.
Overweight and obesity increase the risk of deep vein thrombosis and pulmonary embolism through reduced mobility, higher abdominal pressure, and a more pro-clotting state. Gradual weight loss can help reduce this risk over time.
Smoking damages blood vessels and makes blood more likely to clot. It also increases the chance that a clot will form and later cause a pulmonary embolism or lung infarction.
Risk prevention
Pulmonary embolism and infarction can happen when a blood clot travels to the lungs and blocks blood flow, sometimes damaging nearby lung tissue. The biggest day-to-day goal is preventing clots from forming in the legs and catching warning signs early, especially after surgery, long travel, illness, or time spent in bed. Prevention is about lowering risk, not eliminating it completely. Many living with pulmonary embolism, or those at high risk for it, can lower that risk with a mix of movement, medical care, and attention to personal risk factors.
Long periods of sitting or bed rest slow blood flow in the legs and make clots more likely. Walking regularly, flexing your ankles and calves, and getting up during flights, car rides, or desk work can help lower the risk of pulmonary embolism.
Compression stockings or inflatable leg sleeves can help keep blood moving if you are in the hospital, recovering from surgery, or less mobile than usual. They are most helpful when a clinician recommends them based on your clot risk.
Some people need anticoagulants, often called blood thinners, after surgery, during cancer treatment, or after a previous pulmonary embolism. Taking them exactly as prescribed is one of the most effective ways to prevent another clot.
On trips lasting several hours, try to stand, stretch, and walk whenever you can rather than staying in one position the whole time. Loose clothing, calf exercises in your seat, and good hydration may also help reduce clot risk.
Can you prevent Pulmonary embolism and infarction?
You cannot prevent every case of pulmonary embolism and lung damage from blocked blood flow, but many cases can be partly prevented by lowering the chance of a blood clot forming or traveling to the lungs. The most proven steps are staying as mobile as possible during long trips or bed rest, following care plans after surgery or serious illness, and taking blood-thinning medicine exactly as prescribed if your doctor says you need it. Not smoking and managing conditions that raise clot risk can also help, but they do not guarantee prevention.
Transmission
Pulmonary embolism and infarction cannot be transferred from one person to another, and they are not infectious. A pulmonary embolism happens when a blood clot, often from a deep vein in the leg or pelvis, travels to the lungs; pulmonary infarction is the lung tissue damage that can happen if that blockage cuts off blood flow for too long.
People often ask whether pulmonary embolism is contagious, but it is not something you can catch through close contact, coughing, sex, food, or shared air. What can sometimes run in families is a higher tendency to form blood clots, so some people with pulmonary embolism have an inherited risk factor, but the embolism itself is not passed from one person to another.
When to test your genes
Genetic testing is not routine after a pulmonary embolism. It may be worth discussing if clots happen at a young age, keep returning, occur without a clear trigger, or run strongly in your family. Results can help guide future prevention decisions, especially around pregnancy, estrogen use, or long-term anticoagulation.
Diagnosis
Pulmonary embolism and infarction are usually diagnosed when sudden symptoms, such as sharp chest pain, shortness of breath, or coughing up blood, lead to urgent medical care. Doctors look at symptoms, risk factors, and test results together because these problems can resemble pneumonia, a heart attack, or a panic attack. It’s natural to worry when symptoms don’t have a clear explanation.
Doctors ask about symptoms and timing, including sudden breathlessness, chest pain, fainting, or coughing up blood. They also check for risks such as recent surgery, long travel, cancer, pregnancy, hormone therapy, or a past blood clot.
The exam checks breathing, heart rate, oxygen levels, blood pressure, and signs of strain on the heart or lungs. Doctors also look for swelling, tenderness, or warmth in a leg, which can point to a clot in a deep vein.
A D-dimer blood test can help show whether a clot is unlikely, especially in people with a lower chance of pulmonary embolism and infarction. Other lab tests may help rule out common conditions and check oxygen levels, heart strain, or anemia.
A CT pulmonary angiogram is the main imaging test in many hospitals for the diagnosis of pulmonary embolism and infarction. It uses contrast dye to show blocked lung arteries and can also reveal areas of lung tissue injury caused by poor blood flow.
How is Pulmonary embolism and infarction diagnosed?
Doctors diagnose a pulmonary embolism, and any lung tissue damage it may cause, by putting together your symptoms, medical history, and exam with tests such as oxygen levels, a blood test called D-dimer, and most often a special CT scan with contrast dye that shows whether blood flow to part of the lung is blocked. If a CT scan is not safe or possible, they may use a lung scan, an ultrasound of the legs to look for a clot, or other heart and lung tests to help confirm the cause of symptoms like sudden chest pain or shortness of breath. Lung infarction means part of the lung has been injured because the blood supply was cut off, and it is usually seen on the same imaging rather than diagnosed with a separate test.
Stages of Pulmonary embolism and infarction
Pulmonary embolism and infarction does not have defined progression stages. This is because it usually happens as an acute event rather than a condition that moves through steady, predictable steps over time. Often the process begins when you notice changes in daily life, such as sudden shortness of breath walking across a room or sharp chest pain that is worse with a deep breath, which can be early symptoms of pulmonary embolism. Doctors usually diagnose pulmonary embolism and infarction using your symptoms, an exam, blood tests, and imaging such as a CT scan of the lungs, and they monitor it by watching oxygen levels, heart strain, and how you respond to treatment.
Outlook and prognosis
The outlook for pulmonary embolism with infarction varies widely, but it is generally good when the clot is recognized quickly and treated promptly with anticoagulation and supportive care. Most people who survive the acute event improve over days to weeks, although pleuritic chest pain, shortness of breath, and fatigue can take longer to fully resolve, especially when the infarcted lung tissue is extensive. Prognosis is worse in people with hemodynamic instability, large or recurrent emboli, underlying heart or lung disease, cancer, or delayed diagnosis. Mortality is highest in the first hours to days of a severe pulmonary embolism, while smaller, stable emboli with limited infarction usually have a low short-term death risk with appropriate treatment. Longer-term complications can include recurrent venous thromboembolism and, in a minority of patients, chronic thromboembolic pulmonary hypertension, both of which can affect quality of life and survival. Careful follow-up, attention to clot risk factors, and adherence to the prescribed duration of anticoagulation improve the overall prognosis.
Long-term effects
After a pulmonary embolism and infarction, many people recover well, but some are left with lasting effects that can shape daily life. You might notice getting winded sooner on stairs, needing more time to regain stamina, or having lingering chest discomfort after the clot itself has been treated. Thinking about the long-term effects helps explain why follow-up matters, especially if symptoms do not fully settle. The long-term picture is often different from person to person, depending on how large the clot was, whether lung tissue was damaged, and whether more clots happen later.
Some people have ongoing shortness of breath or reduced exercise tolerance for weeks or months after pulmonary embolism and infarction. For many, this can mean needing to pause during a walk, climbing stairs more slowly, or feeling unusually tired after routine activity.
Lung infarction can leave irritation or scarring in the affected area, which may cause lingering chest pain, especially with deep breaths or coughing. This is not the most common long-term effect, but it can happen after a larger area of lung tissue has been injured.
Even when oxygen levels are normal at rest, some living with pulmonary embolism notice they become lightheaded or more easily winded with exertion. This can be more noticeable in people who already have lung or heart disease.
One of the main long-term concerns after pulmonary embolism is another blood clot in the lungs or legs. New swelling in one leg, sudden chest pain, or the early symptoms of pulmonary embolism should be checked urgently.
How is it to live with Pulmonary embolism and infarction?
After a pulmonary embolism, daily life can feel suddenly less predictable: many people living with it notice shortness of breath, chest discomfort, fatigue, or anxiety about symptoms returning, and recovery may be slower if part of the lung was injured by infarction, meaning a small area lost blood flow and became damaged. For many, this can mean taking blood-thinning medicine every day, going to follow-up visits, avoiding injury because of bleeding risk, and easing back into exercise, work, and travel with medical guidance rather than all at once. The effects often reach the people around you too, because family or friends may help with appointments, watch for warning signs, and adjust routines while recovery and confidence rebuild, but with treatment and follow-up, many people gradually return to a more normal rhythm.
Treatment and drugs
Pulmonary embolism and infarction is usually treated as a medical emergency, because a blood clot in the lungs can quickly cause shortness of breath, chest pain, and low oxygen levels that make even simple tasks like walking across a room feel hard. The main treatment is blood-thinning medicine, also called anticoagulants, which helps stop the clot from growing and lowers the chance of new clots. In more severe cases, especially if blood pressure is low or the heart is under strain, doctors may use clot-busting drugs or procedures to break up or remove the clot. Treatment plans often combine several approaches. Many living with pulmonary embolism and infarction stay on blood thinners for months, and some need longer treatment depending on what caused the clot and their risk of another one.
Can you cure Pulmonary embolism and infarction?
There is not a single instant cure for pulmonary embolism and infarction, but it can often be treated well, and many people recover, especially when care starts quickly. Treatment usually uses blood-thinning medicine to stop the clot from growing and lower the chance of new clots, and some people may also need medicine or a procedure to break up or remove the clot, along with oxygen and pain relief. The injured part of the lung often heals over time, but some people living with this condition can have lasting lung problems or need ongoing treatment to help prevent it from happening again.
Non-drug treatment
Pulmonary embolism and infarction can leave people suddenly short of breath, worn out, and anxious about moving around or taking a deep breath. Managing this condition often includes supportive care and procedures that help the body get enough oxygen, protect the lungs, and lower the chance of another clot. The right plan depends on how severe the blockage is, whether part of the lung has been injured, and how stable breathing and blood pressure are. Some people improve quickly, while others need extra help during recovery after pulmonary embolism.
Extra oxygen can raise blood oxygen levels when breathing feels tight or shallow. This may be given through a small tube under the nose or a face mask while the lungs recover.
Many people with pulmonary embolism need close monitoring at first, especially if they have low oxygen, chest pain, or strain on the heart. This helps the care team respond quickly if breathing, pulse, or blood pressure worsens.
In severe pulmonary embolism, doctors may use catheter-based treatment or surgery to break up or remove the clot. These options are usually reserved for emergencies or when standard treatment is not possible.
Compression stockings or inflatable leg sleeves can help blood keep moving in the legs and lower the risk of new clots in some situations. They are most often used during hospital stays or when someone is less mobile than usual.
Your genes may have an impact on how drugs work for you
For people being treated for a pulmonary embolism, the biggest day-to-day issue is usually how well blood thinners work and whether they raise the chance of bleeding too much or not enough. Small inherited differences in the body can change how some of these medicines are processed, so one person may need a lower dose while another may need more careful dose changes; a well-known example is warfarin, where genetic testing can sometimes help guide safer dosing. This kind of gene-based medicine is called pharmacogenomics, but for pulmonary embolism it matters most with certain older blood thinners, while many newer options are less affected by these inherited differences.
Pharmacological treatments
Treatment for pulmonary embolism and infarction usually starts with medicines that stop the clot from growing and lower the chance of new clots forming. Many people with pulmonary embolism move from an early blood thinner given right away to a longer-term medicine taken for weeks or months, depending on the cause and bleeding risk. Not everyone responds to the same medication in the same way. In severe cases, doctors may use a clot-busting drug to restore blood flow more quickly.
Unfractionated heparin, enoxaparin, and dalteparin are commonly used at the start of treatment because they begin working quickly. They help prevent the clot from getting larger while the body slowly breaks it down.
Fondaparinux is another injectable blood thinner that may be used early in pulmonary embolism, especially when a simple once-daily shot is preferred. It lowers the risk of new clotting but, like all blood thinners, can raise the risk of bleeding.
Apixaban and rivaroxaban can often be started early, while dabigatran and edoxaban are usually started after a few days of an injectable blood thinner. These medicines are widely used for long-term treatment because they do not usually need the regular blood test monitoring required with warfarin.
Warfarin is an older oral blood thinner that is still used for some people with pulmonary embolism, including some with kidney problems, certain valve conditions, or cost concerns. It takes several days to work fully, so it is often overlapped at first with heparin or a similar drug.
Genetic influences
For some people, a blood clot in the lung happens after a long hospital stay, major surgery, pregnancy, or estrogen medicines, but inherited clotting tendency can also raise the odds. Family history is one of the strongest clues to a genetic influence. A few gene changes make blood more likely to clot, including well-known ones such as factor V Leiden or the prothrombin variant, and rarer inherited shortages of the body’s natural anti-clotting proteins can do the same.
These genetic factors do not guarantee pulmonary embolism and infarction; many living with them never have a clot, while others develop problems only when another trigger is present. Doctors may think more about inherited risk when pulmonary embolism happens at a younger age, keeps coming back, or appears in several close relatives. If that pattern is present, genetic counseling or targeted blood-clot testing may help guide future prevention for you and your family.
Is Pulmonary embolism and infarction genetic?
Genetics can matter in pulmonary embolism and infarction, but they are usually only part of the risk. Some inherited clotting tendencies can raise the chance of blood clots, while surgery, cancer, pregnancy, hormones, or long periods of immobility often play a bigger role.
Having a genetic risk is not necessarily a diagnosis
Gene changes are a normal part of human biology and are common in the general population. Most of these changes do not directly affect health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When treatment begins, one of the biggest questions is which blood thinner will be safest and most effective for pulmonary embolism and infarction. Genes do not usually decide whether you need treatment, but they can affect how your body handles certain medicines, especially warfarin. Genetic testing can sometimes identify how your body processes warfarin, which may help doctors choose a safer starting dose and lower the chance of bleeding or under-treatment. For most newer blood thinners used for pulmonary embolism, routine genetic testing is not standard, because kidney function, liver health, age, other medicines, and bleeding risk often matter more. Some inherited clotting traits can also influence how long treatment is recommended after a pulmonary embolism, particularly if the event was not clearly triggered by surgery, immobility, or another temporary cause. If you are reading about genetic testing for pulmonary embolism treatment, it is most useful when the result would actually change the blood thinner or dose chosen for you.
Interactions with other conditions
Pulmonary embolism and infarction can become more serious when they happen alongside heart or lung disease, because there is less reserve to cope with a sudden drop in oxygen or blood flow. For many, this can mean that symptoms such as shortness of breath, chest pain, or a racing heartbeat feel worse than expected, especially if they already live with chronic obstructive pulmonary disease, asthma, heart failure, or coronary artery disease. Doctors call it a “comorbidity” when two conditions occur together. Pulmonary embolism and infarction may also be more likely in people with cancer, recent major surgery, long periods of immobility, or inflammatory illnesses, since these can increase the tendency for blood to clot. In day-to-day life, someone might notice their breathing becomes much harder during a flare of another lung condition, which can make the early symptoms of pulmonary embolism easier to miss. Because treatment often involves blood thinners, other illnesses such as stomach ulcers, liver disease, or kidney disease can also affect which medicines are safest and how closely doctors need to monitor care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Pulmonary embolism and infarction?
Pulmonary embolism and lung infarction, which means a blood clot in the lung with damage to part of the lung, can look a lot like a heart attack, pneumonia, a collapsed lung, or a bad flare of asthma or COPD. It can also be mistaken for a panic attack, since both can cause sudden shortness of breath, chest pain, dizziness, and a fast heartbeat. Because these problems can overlap so much, sudden chest pain, trouble breathing, or coughing up blood needs urgent medical care.
History
Throughout history, people have described sudden chest pain, coughing up blood, and collapse after long periods of illness, childbirth, surgery, or being confined to bed, even when the cause was not clear at the time. For many living in earlier centuries, these events seemed to come out of nowhere: someone might be recovering well, then suddenly become very short of breath walking across a room or turning in bed.
In the 1800s, doctors began linking these sudden events to blood clots that formed in the deep veins, usually in the legs, and then traveled to the lungs. This helped shape the modern understanding of pulmonary embolism and infarction, including why some people develop a blocked lung artery and why part of the lung may lose its blood supply and become damaged. Not every early description was complete, yet together they built the foundation of today’s knowledge.
By the late 19th and early 20th centuries, autopsies gave doctors a clearer picture of what was happening inside the body. They could see clots in the lung arteries and, in some cases, wedge-shaped areas of injured lung tissue, which is what doctors mean by pulmonary infarction. Over time, it became clear that not every pulmonary embolism causes an infarction, and that the risk can depend on how large the clot is, where it lodges, and how healthy the heart and lungs were beforehand.
As medical science evolved, doctors also recognized common risk situations. Long recovery after surgery, cancer, pregnancy and the weeks after delivery, and extended immobility all stood out. During the 20th century, hospital care changed in response, with earlier movement after illness or surgery and medicines to lower clot risk becoming more routine.
The history of pulmonary embolism also changed with better testing. In the past, many cases were only found after death or strongly suspected from symptoms. Today, imaging scans, blood tests, and ultrasound of the legs can often identify the problem much earlier. That matters because early symptoms of pulmonary embolism and infarction, such as sudden breathlessness, sharp chest pain, or coughing up blood, can overlap with other conditions.
In recent decades, awareness has grown that pulmonary embolism can affect many different people, not only those who are critically ill in the hospital. Some may develop it after a long flight, after an injury, or during cancer treatment, while others have more than one risk factor at the same time. Looking back at this history helps explain why quick recognition and treatment are now such an important part of care.